Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Alefacept (formerly sold as Amevive) is an immunosuppressive fusion protein that was approved by the FDA in 2003 to treat moderate-to-severe chronic plaque psoriasis. The manufacturer voluntarily discontinued and withdrew the drug globally in 2011.
Alefacept (formerly sold as Amevive) is an immunosuppressive fusion protein that was approved by the FDA in 2003 to treat moderate-to-severe chronic plaque psoriasis. The manufacturer voluntarily discontinued and withdrew the drug globally in 2011.